Advances in biomarkers and endogenous regulation of breast cancer stem cells. Cells, 2022

Title:Advances in biomarkers and endogenous regulation of breast cancer stem cells

Author:Chen W, Zhang L, Liu S, Chen C.

Publication Name: Cells

Pub Year: 2022

Doi:10.3390/cells11192941

IF: 7.666

Abstract:
Breast cancer is one of the most common cancers. Even if breast cancer patients initially respond to treatment, developed resistance can lead to a poor prognosis. Cancer stem cells (CSCs) are a group of undifferentiated cells with self-renewal and multipotent differentiation characteristics. Existing evidence has shown that CSCs are one of the determinants that contribute to the heterogeneity of primary tumors. The emergence of CSCs causes tumor recurrence, metastasis, and therapeutic resistance. Previous studies indicated that different stemness-associated surface markers can identify other breast cancer stem cell (BCSC) subpopulations. Deciphering the critical signaling networks that are involved in the induction and maintenance of stemness is essential to develop novel BCSC-targeting strategies. In this review, we reviewed the biomarkers of BCSCs, critical regulators of BCSCs, and the signaling networks that regulate the stemness of BCSCs.